The National Primary Health Care Development Agency (NPHCDA) has stated there is no plan to discontinue the use of Oxford AstraZeneca vaccine.
The agency, in a statement on Saturday, affirmed Nigeria is continuing the process of administering roughly 4 million doses of the Oxford/AstraZeneca vaccine beginning with frontline health workers and vulnerable individuals.
It said: “There has been no change to current plans or supply.
“A huge number of countries around the world are administering the Oxford/AstraZeneca vaccine, including much of Europe, and the United Kingdom which has administered the most doses of AstraZeneca globally.
“The World Health Organisation, British and European health regulators all continue to advocate for the use of AstraZeneca.
“AstraZeneca’s strong effectiveness against COVID-19 has been demonstrated in clinical and human trials: it has been shown to be 76% effective at preventing COVID-19 and 100% effective at preventing severe disease and hospitalisation.
- BREAKING: NAFDAC approves Moderna, AstraZeneca, Sputnik V COVID-19 vaccines for emergency use
- NAFDAC Approves Emergency Use Of Johnson & Johnson COVID-19 Vaccine
- Only 23 per cent of health workers vaccinated